Cardiomyocyte glucagon receptor signaling modulates outcomes in mice with experimental myocardial infarction

OBJECTIVE: Glucagon is a hormone with metabolic actions that maintains normoglycemia during the fasting state. Strategies enabling either inhibition or activation of glucagon receptor (Gcgr) signaling are being explored for the treatment of diabetes or obesity. However, the cardiovascular consequenc...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Mol Metab
Päätekijät: Ali, Safina, Ussher, John R., Baggio, Laurie L., Kabir, M. Golam, Charron, Maureen J., Ilkayeva, Olga, Newgard, Christopher B., Drucker, Daniel J.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Elsevier 2014
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4314543/
https://ncbi.nlm.nih.gov/pubmed/25685700
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molmet.2014.11.005
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia